Evidence map›Paper›PMID 32455658›Full record

ReviewJournal of clinical medicine2020

Preoperative, Intraoperative and Postoperative Corticosteroid Use as an Adjunctive Treatment for Rhegmatogenous Retinal Detachment.

Vincenza Bonfiglio, Michele Reibaldi, Iacopo Macchi, Matteo Fallico, Corrado Pizzo, Clara Patane, Andrea Russo, Antonio Longo, Alessandra Pizzo, Giovanni Cillino and 8 more

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Journal of clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05331664 (Dropless Pars Plana Vitrectomy Study), which is not on this map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05331664 phase4recruitingnot on this mapstarted 2022, after this paper: background citation

Dropless Pars Plana Vitrectomy Study

TypeinterventionalSponsorMassachusetts Eye and Ear InfirmaryRan2022 to 2027Enrolled168ConditionsRhegmatogenous Retinal DetachmentArmsPars plana vitrectomy, Triamcinolone Acetonide 40mg/mL, Moxifloxacin 0.5% or Polymyxin/Trimethoprim if patient is allergic to moxifloxacin, Prednisolone 1%, Atropine 1%
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 2 countries.

Vincenza BonfiglioDepartment of Experimental Biomedicine and Clinical Neuroscience, Ophthalmology Section, University of Palermo, 90127 Palermo, Italy.
Michele ReibaldiDepartment of Surgical Sciences, Eye Clinic Section, University of Turin, 10122 Turin, Italy.ORCID 0000-0003-1368-6729
Iacopo MacchiDepartment of Ophthalmology, University of Catania, 95100 Catania, Italy.
Matteo FallicoDepartment of Ophthalmology, University of Catania, 95100 Catania, Italy.
Corrado PizzoDepartment of Ophthalmology, University of Catania, 95100 Catania, Italy.
Clara PataneDepartment of Experimental Biomedicine and Clinical Neuroscience, Ophthalmology Section, University of Palermo, 90127 Palermo, Italy.
Andrea RussoDepartment of Ophthalmology, University of Catania, 95100 Catania, Italy.ORCID 0000-0002-7725-5971
Antonio LongoDepartment of Ophthalmology, University of Catania, 95100 Catania, Italy.ORCID 0000-0002-9525-1800
Alessandra PizzoDepartment of Ophthalmology, University of Catania, 95100 Catania, Italy.
Giovanni CillinoDepartment of Experimental Biomedicine and Clinical Neuroscience, Ophthalmology Section, University of Palermo, 90127 Palermo, Italy.
Salvatore CillinoDepartment of Experimental Biomedicine and Clinical Neuroscience, Ophthalmology Section, University of Palermo, 90127 Palermo, Italy.ORCID 0000-0002-5721-6772
Maria VadalàDepartment of Experimental Biomedicine and Clinical Neuroscience, Ophthalmology Section, University of Palermo, 90127 Palermo, Italy.
Michele RinaldiDepartment of Ophthalmology, Second University of Naples, 80131 Naples, Italy.
Robert RejdakDepartment of General Ophthalmology, Medical University of Lublin, 20079 Lublin, Poland.
Katarzyna NowomiejskaDepartment of General Ophthalmology, Medical University of Lublin, 20079 Lublin, Poland.
Mario Damiano ToroDepartment of General Ophthalmology, Medical University of Lublin, 20079 Lublin, Poland.ORCID 0000-0001-7152-2613
Teresio AvitabileDepartment of Ophthalmology, University of Catania, 95100 Catania, Italy.
Elina OrtisiDepartment of Ophthalmology, University of Catania, 95100 Catania, Italy.
University of Catania · ITMedical University of Lublin · PLUniversity of Palermo · ITUniversity of Campania "Luigi Vanvitelli" · ITUniversity of Turin · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The treatment for rhegmatogenous retinal detachment (RRD) is surgery, including pars plana vitrectomy (PPV) and scleral buckling (SB). Despite surgical advances, degeneration of the photoreceptors and post-operative complications, such as proliferative vitreoretinopathy (PVR), often occurs as the result of inflammation, preventing complete visual recovery or causing RRD recurrence. There is increasing evidence that in the presence of RRD, the activation of inflammatory processes occurs and the surgery itself induces an inflammatory response. This comprehensive review focuses on the use of different formulations of corticosteroids (CCS), as an adjunctive treatment to surgery, either PPV or SB, for RRD repair. The purpose was to review the efficacy and safety of CCS in improving functional and anatomical outcomes and in preventing postoperative complications. This review is organized according to the timing of CCS administration: preoperative, intraoperative, and postoperative. The evidence reviewed supported the role of the pre-operative use of CCS in the treatment of combined RRD and choroidal detachment (CD), reducing CD height. No solid consensus exists on intraoperative and postoperative use of CCS to treat and prevent postoperative complications. However, a large randomized clinical trial including more than 200 eyes suggested that oral prednisone after surgery decreases the rate of postoperative grade B PVR.

Indexed as

corticosteroidsdexamethasonefluocinolonerhegmatogenous retinal detachmentscleral bucklingtriamcinolonevitrectomy

Identifiers

PMID32455658
PMCPMC7290919
OpenAlexW3027197561

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.